EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION

European Medicines Agency approved apixaban use in cardioversion.

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: Столичная издательская компания 2015-09-01
Series:Рациональная фармакотерапия в кардиологии
Online Access:https://www.rpcardio.online/jour/article/view/268
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227952386998272
collection DOAJ
description European Medicines Agency approved apixaban use in cardioversion.
format Article
id doaj-art-94ef188219254b05bf5a01f258a38f2b
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2015-09-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-94ef188219254b05bf5a01f258a38f2b2025-08-23T10:00:18ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-01103268EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSIONEuropean Medicines Agency approved apixaban use in cardioversion.https://www.rpcardio.online/jour/article/view/268
spellingShingle EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
Рациональная фармакотерапия в кардиологии
title EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_full EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_fullStr EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_full_unstemmed EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_short EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_sort european medicines agency approved apixaban use in cardioversion
url https://www.rpcardio.online/jour/article/view/268